Y10S 977/916
Gene therapy
Y10S977/916 (Gene therapy) appears on 84 US grants and 46 published applications in this corpus.
Search patents in Y10S- Granted patents
- 84
- Published applications
- 46
- Assignees
- 55
- Inventors
- 137
- Latest grant
- 2 Jul 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 6 | 0 |
| 2000 | 10 | 0 |
| 2001 | 15 | 2 |
| 2002 | 10 | 9 |
| 2003 | 13 | 7 |
| 2004 | 4 | 4 |
| 2005 | 1 | 3 |
| 2006 | 3 | 0 |
| 2007 | 0 | 2 |
| 2008 | 2 | 0 |
| 2009 | 0 | 4 |
| 2010 | 1 | 1 |
| 2011 | 4 | 2 |
| 2012 | 2 | 4 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 2 | 1 |
| 2016 | 3 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Block copolymers and uses thereof2 Jul 2019US 10,335,499 B2Ecole Polytechnique Federale De Lausanne (Epfl)
- Chromosome 3p21.3 genes are tumor suppressors17 Apr 2018US 9,944,951 B2Board of Regents, The University of Texas System
- Low molecular weight cationic lipids for oligonucleotide delivery8 Aug 2017US 9,725,720 B2Sirna Therapeutics, Inc.
- Low molecular weight cationic lipids for oligonucleotide delivery4 Oct 2016US 9,458,087 B2Sirna Therapeutics, Inc.
- Method for synthesizing spherical porous titanium oxide nanoparticles, spherical porous titanium oxide nanoparticles produced by said synthesis method, and carrier for gene gun which comprises said spherical porous titanium oxide nanoparticles10 May 2016US 9,334,174 B2Kochi University of Technology
- Block copolymers and uses thereof2 Jan 2025US 2025/0001005 A1Ecole Polytechnique Federale De Lausanne (Epfl)
- Block copolymers and uses thereof2 Jun 2022US 2022/0168448 A1Ecole Polytechnique Federale De Lausanne (Epfl)
- Block copolymers and uses thereof2 Jan 2020US 2020/0000936 A1Ecole Polytechnique Federale De Lausanne (Epfl)
- Low molecular weight cationic lipids for oligonucleotide delivery19 Jan 2017US 2017/0015998 A1Sirna Therapeutics, Inc.
- Block copolymers and uses thereof8 Sep 2016US 2016/0256569 A1Ecole Polytechnique Federale De Lausanne (Epfl)
Most cited
By later US patents
- Preparation of nanocrystallites375US 6,576,291 B2Massachusetts Institute of Technology · 2003
- Therapeutic inhibitor of vascular smooth muscle cells245US 6,171,609 B2NeoRx Corporation · 2001
- Therapeutic inhibitor of vascular smooth muscle cells171US 6,515,009 B1NeoRx Corporation · 2003
- Methods of isolating biological target materials using silica magnetic particles153US 6,027,945 APromega Corporation · 2000
- Sterile aspiration/reinjection systems150US 6,796,957 B2Myocardial Therapeutics, Inc. · 2004